Multiple Myeloma | Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 2

Research To Practice | Oncology Videos · Dec 2, 2022 · 1h 4m

Featuring perspectives from Dr Paul Richardson, including the following topics:

Introduction (0:00)

Case: A man in his early 60s with newly diagnosed Stage II standard-risk multiple myeloma — Ranju Gupta, MD (29:31)

Case: A woman in her early 70s with Stage IIIA multiple myeloma who receives lenalidomide/bortezomib/dexamethasone → autologous stem cell transplant (ASCT) and discontinues maintenance lenalidomide after 3 years — Erik Rupard, MD (34:16)

Case: A woman in her early 70s with relapsed myeloma after tandem ASCT who receives cyclophosphamide/bortezomib/dexamethasone, achieves minimum…